IKBKG Gene - Inhibitor of Nuclear Factor Kappa B Kinase Subunit Gamma

Essential regulator of NF-κB signaling and immune response

Gene Information Card

Symbol IKBKG
Full Name Inhibitor of Nuclear Factor Kappa B Kinase Subunit Gamma
Gene Type Protein coding
Chromosomal Location Xq28
NCBI Gene ID 8517 ncbi.nlm.nih.gov/gene/8517
Ensembl ID ENSG00000069399
UniProt ID Q9Y6K9
OMIM ID 300248
HGNC ID 5961
Aliases NEMO, FIP3, FIP-3, IKKAP1, IKK-gamma, IP1, IP2, IPD2, NEMO1, ZC2HC9

Description

The IKBKG gene encodes the regulatory subunit of the inhibitor of kappa B kinase (IKK) complex, known as NEMO (NF-κB essential modulator). This protein is critical for activating the NF-κB transcription factor, which regulates immune responses, inflammation, cell survival, and development. Mutations in IKBKG cause X-linked primary immunodeficiencies and ectodermal dysplasia syndromes.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Incontinentia Pigmenti Loss-of-function mutations in IKBKG disrupt NF-κB activation, leading to X-linked dominant male-lethal disorder with skin, hair, and neurological abnormalities. OMIM #308300
Ectodermal Dysplasia, Anhidrotic, with Immunodeficiency (EDA-ID) Hypomorphic mutations impair NF-κB signaling, causing defective development of ectodermal tissues and severe immune deficiency. OMIM #300291
Immunodeficiency 33 (IMD33) Specific IKBKG mutations result in recurrent infections, hyper-IgM syndrome, and impaired antibody responses. OMIM #300636

Expression Profile

Tissue Expression
Tissue nTPM level
Whole blood 12.3 Medium
Lymph node 10.8 Medium
Spleen 9.5 Medium
Bone marrow 8.2 Low
Skin 6.1 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 Cervical carcinoma
K-562 11.4 Leukemia
HEK 293 9.8 Embryonic kidney
Jurkat 14.1 T-cell leukemia
HepG2 7.3 Hepatocellular carcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1167dupC (p.Glu390Argfs*4) Frameshift Common in incontinentia pigmenti Loss of function
c.1056_1058del (p.Glu352del) In-frame deletion Rare Dominant negative
c.397A>G (p.Met133Val) Missense Associated with EDA-ID Hypomorphic
Mutation functional classification

Loss of Function (LOF)

Complete loss of NEMO function leads to incontinentia pigmenti (male lethal) and severe immunodeficiency.

Gain of Function (GOF)

Not reported for IKBKG; gain-of-function mutations are not described in literature.

Dominant Negative (DN)

Some missense or in-frame deletions (e.g., p.Glu352del) produce a dominant-negative effect, impairing IKK complex assembly.

Pathways

NF-kappa B signaling pathway (KEGG: hsa04064)
Toll-like receptor signaling pathway (KEGG: hsa04620)
RIG-I-like receptor signaling pathway (KEGG: hsa04622)
NOD-like receptor signaling pathway (KEGG: hsa04621)

Protein Summary

NEMO (IKK-gamma) is a 48 kDa scaffold protein that forms the regulatory subunit of the IKK complex. It contains a coiled-coil region, a leucine zipper, and a zinc finger domain. NEMO binds to IKKα and IKKβ, enabling activation of the IKK complex by upstream signals. It is essential for canonical NF-κB activation, which controls transcription of genes involved in immunity, inflammation, and cell survival.

Related Products

Product name Cat.No. Species Gene ID
IKBKG Knockout HEK293T Cell Line EDJ-KQ207 Human 8517 Details Get a Quote
IKBKG Knockout HEK293 Cell Line EDJ-KQ567 Human 8517 Details Get a Quote
IKBKG Knockout A-549 Cell Line EDJ-KQ18956 Human 8517 Details Get a Quote
IKBKG Knockout HCT 116 Cell Line EDJ-KQ18957 Human 8517 Details Get a Quote
IKBKG Knockout HeLa Cell Line EDJ-KQ18958 Human 8517 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: